Jerome Cambre - May 9, 2023 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role
Vice President of Sales
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Stock symbol
VMD
Transactions as of
May 9, 2023
Transactions value $
-$20,497
Form type
4
Date filed
5/11/2023, 04:33 PM
Previous filing
Jan 20, 2023
Next filing
Jan 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Options Exercise +924 +1.4% 66.8K May 9, 2023 Direct F1
transaction VMD Common Shares Disposed to Issuer -$9.7K -924 -1.38% $10.50 65.9K May 9, 2023 Direct
transaction VMD Common Shares Options Exercise +1.03K +1.56% 66.9K May 9, 2023 Direct F1
transaction VMD Common Shares Disposed to Issuer -$10.8K -1.03K -1.54% $10.50 65.9K May 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VMD Phantom Share Units Options Exercise $0 -924 -100% $0.00* 0 May 9, 2023 Common Shares 924 Direct F2, F3
transaction VMD Phantom Share Units Options Exercise $0 -1.03K -50.02% $0.00 1.03K May 9, 2023 Common Shares 1.03K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F2 Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
F3 Represents an award granted in 2020 under the Issuer's Phantom Share Unit Plan which vested on May 9, 2023.
F4 Represents an award granted in 2021 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2023 and May 9, 2024, subject to the Reporting Person's continued employment with the Issuer on such vesting date.